Vimarsana
Biggest News Aggregation in the World

Alphamed Press News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alphamed Press. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alphamed Press Today - Breaking & Trending Today

Bone marrow stem cell transplants can benefit some Type 2 diabetes patients, study shows - Vimarsana News

Bone marrow stem cell transplants can benefit some Type 2 diabetes patients, study shows

 E-Mail IMAGE: Research team from Vinmec Research Institute of Stem Cell and Gene Technology in Hanoi, Vietnam. view more  Credit: AlphaMed Press Durham, NC -- Type 2 diabetes patients who are not overweight and who have had the disorder for less than a decade can benefit from stromal stem cells transplanted from their own bone marrow, according to a study published today in STEM CELLS Translational Medicine. In a randomized clinical trial at Vinmec Research Institute of Stem Cell and Gene Technology in Hanoi, Vietnam, researchers investigated the safety and potential therapeutic v...

From mice to men: Study reveals potential new target for treating acute myeloid leukemia - Vimarsana News

From mice to men: Study reveals potential new target for treating acute myeloid leukemia

Credit: AlphaMed Press Durham, NC -- Bone marrow failure due to acute myeloid leukemia (AML) is a significant factor behind the disease's high rate of morbidity and mortality. Previous studies in mice suggest that AML cells inhibit healthy hematopoietic (blood) stem and progenitor cells (HSPC). A study released in STEM CELLS adds to this extent of knowledge by showing how secreted cell factors, in particular a protein called transforming growth factor beta 1 (TGFβ1), leads to a breakdown in the production of healthy blood cells (a process called hematopoiesis) in humans. The study's findin...

Human mesenchymal stem cells show promise in treating chronic lung infections - Vimarsana News

Human mesenchymal stem cells show promise in treating chronic lung infections

A study released in STEM CELLS Translational Medicine offers hope for those suffering from a chronic, difficult to treat condition called non-tuberculous mycobacteria (NTM) lung infection.

Clinical trial assesses stem cells' ability to prevent major cause of preemie deaths - Vimarsana News

Clinical trial assesses stem cells' ability to prevent major cause of preemie deaths

Credit: AlphaMed Press Durham, NC - A phase 2 clinical trial whose results were released today in STEM CELLS Translational Medicine might point to a way to overcome bronchopulmonary dysplasia (BPD), a major cause of death in preterm infants. The study, conducted by researchers at Samsung Medical Center, Sungkyunkwan University and Asan Medical Center Children's Hospital in Seoul, evaluates the effectiveness of treating these infants by transplanting umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs) directly into their tracheas. Early results showed signs of improvement for the ...

Stem cells derived from fat show promise as a treatment for mass radiation exposure - Vimarsana News

Stem cells derived from fat show promise as a treatment for mass radiation exposure

 E-Mail IMAGE: Allogeneic adipose-derived stem cells rescue irradiation bone marrow cells via secretion of pro-survival and hematopoietic factors. view more  Credit: AlphaMed Press Durham, NC - Nuclear power offers an efficient, reliable way to provide energy to large populations - as long as all goes well. Accidents involving nuclear reactors such as those that took place in 1986 at Chernobyl and at Fukushima Daiichi after the March 2011 tsunami raise major concerns about what happens if the worst occurs and large numbers of people are simultaneously exposed to high levels of radia...